Poonawalla’s announcement comes amid reports that RCB may not play their home matches in Bengaluru during the IPL 2026 season. Cities such as Pune, Mumbai and Raipur have reportedly approached the franchise to host their matches. 

‘Will place strong bid in coming months’: Adar Poonawalla confirms interest in RCB ownership

Adar Poonawalla, the CEO of the Serum Institute of India and chairman of the Poonawalla Fincorp, has expressed interest in buying Royal Challengers Bengaluru (RCB).


Serum Institute of India CEO Adar Poonawalla Wants to Buy RCB

Karan Johar’s Dharma Productions, one of India's biggest film companies recently created a buzz after it sold half its ownership to Adar Poonawalla for Rs 1000 crore.

Yash Johar’s legacy: Why did Karan Johar sell Dharma Production’s 50 per cent stake?

Serum Institute of India CEO Adar Poonawalla has purchased a 50 per cent stake in Dharma Productions, owned by Karan Johar. The Rs 1,000 crore ($120 million) acquisition, made through Poonawalla's company Serene Entertainment, includes both Dharma Productions and its streaming arm, Dharmatic Entertainment.

Kabhi Khushi Kabhi Serum: Jaaved Jaaferi mocks Karan Johar for selling Dharma Productions stake to Poonawala

Serum Institute Of India's Adar Poonawalla is all set to acquire 50% stake in Dharma Productions which was started by Karan Johar. According to reports, Johar will continue to be the company's Executive Chairman and his partner Apoorva Mehta will remain the Chief Executive Officer and help Johar to steer the strategic directions of the company and oversee the operations.

Karan Johar sells half of Dharma Production's stakes to Serum Institute's Adar Poonawalla

India's vaccine king, Adar Poonawalla, has closed the deal to buy London's most expensive house of 2023. The billionaire has splashed out a whopping £138 million for the house, a 1920s mansion that will be acquired by the UK subsidiary of his company, the Serum Institute of India.

Gravitas | London's most expensive mansion of 2023 sold for £138 million | Here's Who Bought It

Indian billionaire Adar Poonawalla, the CEO of Serum Institute of India (SII), has closed a deal to buy a 25,000-square-foot Aberconway House in Mayfair, London priced at $174 million, according to a Financial Times report.

Billionaire vaccine maker Adar Poonawalla to buy most expensive house in London. Here's how much it will cost

Serum Institute of India (SII) CEO Adar Poonawalla confirmed on Thursday that the company had stopped making new Covid-19 vaccines back in December 2021 and also had to dump at least 100 million doses after they expired.

India: Vaccine maker SII forced to destroy 100 million doses of expired Covid vaccine

Indonesia's government said in a statement that President Joko Widodo met Tesla Inc Chief Executive Elon Musk in Texas on Saturday. Widodo and Musk discussed potential investments and technology amid speculation that Tesla may choose Indonesia for a manufacturing base in Asia.

President Joko Widodo meets Elon Musk amid speculation that Tesla may choose Indonesia for manufacturing base

Adar Poonawalla, CEO of the Serum Institute of India (SII) in Pune, confirmed on Wednesday (May 4) in his tweet that the COVID-19 vaccination Covovax will now be available to everyone above the age of 12 years.

Covovax vaccine available for everyone above 12 years: Adar Poonawalla

In two to three weeks, it will be clear how effective Covishield vaccine is against COVID-19 variant Omicron, Adar Poonawalla, the chief of Serum Institute of India which manufactures the Indian version of the Oxford-AstraZeneca vaccine, told a news channel on Monday.

Will Covishield work against Omicron? It will be clear in 2-3 weeks, says Serum Institute’s Poonawalla

Indian Prime Minister Narendra Modi met seven Indian Covid vaccine manufacturers, including Serum Institute of India’s chief Adar Poonawalla. This meeting took place a few days after India achieved a historic milestone of administering one billion COVID-19 vaccines to eligible population.

PM Modi meets Covid vaccine manufacturers after India administers 1 billion doses

After defaulting on orders worth millions of dollars, Adar Poonawalla now says 'capacity cannot be expanded overnight'. Why did he make promises that were impossible to keep? WION's Palki unmasks the man behind the facade of 'Vaccine Prince'.

Gravitas: India's Vaccine Prince unmasked

Adar Poonawalla, the CEO of Serum Institute of India made a startling claim in an interview to a UK newspaper. In the interview, Poonawalla said that he received 'threats' from powerful people for delivery of vaccines.

'I received threats', says Serum Institute CEO Adar Poonawalla

Serum Institute of India CEO Adar Poonawalla has said that the production of COVID-19 vaccine Covishield is in full swing in Pune and he will review the operations once he is back in the country.

Serum Institute of India CEO Adar Poonawalla alleges - 'I received threats'

Amid a surge in coronavirus cases in India, the CEO of Serum Institute of India (SII) said it will reduce the price of the Covishield vaccine by INR 100. The price of the vaccine has been reduced from 400 rupees to 300 per dose for all Indian states, said an announcement by Adar Poonawalla on Wednesday.

After row, Serum Institute cuts price of its Covid vaccine to 300 rupees for states as 'philanthropic gesture'

The Serum Institute of India (SII) has requested the US President Joe Biden to lift an embargo on US exports of raw materials to smoothen the production of vaccine shots.

SII's Adar Poonawalla urges Joe Biden to lift embargo of raw materials for vaccine

Serum Institute of India is expecting the Indian government to give approval to the Oxford-AstraZeneca coronavirus vaccine for emergency use in the next few days, the company said on Monday.

India to approve AstraZeneca-Oxford vaccine soon: Adar Poonawalla

The United Nations Covid-19 summit passed up a pre-recorded video message from Adar Poonawalla, CEO of the world`s largest vaccine manufacturer, who was scheduled to speak in an afternoon session headlined `The Road to a COVID-19 Vaccine - a Global Public Good.

Citing tech issues, UN Covid-19 summit nixes Adar Poonawalla video

Oxford is developing a COVID-19 vaccine with Serum Institute of India, and as the trials further, the CEO Adar Poonawalla has claimed that the vaccine will be available till the end of the year.

Oxford's COVID-19 vaccine will be ready by December: Serum Institute CEO Adar Poonawalla

adar-poonawalla

Adar Poonawalla, News on Adar Poonawalla, stories on Adar Poonawalla, articles on Adar Poonawalla, Adar Poonawalla stories at Wion, Adar Poonawalla news, Adar Poonawalla latest news

adar poonawalla